Show simple item record

dc.creatorTolić, Anja
dc.creatorRajić, Jovana
dc.creatorĐorđević, Miloš
dc.creatorĐorđević, Marija
dc.creatorUskoković, Aleksandra
dc.creatorGrdović, Nevena
dc.creatorMihailović, Mirjana
dc.creatorArambašić Jovanović, Jelena
dc.creatorDinić, Svetlana
dc.creatorNestorović, Nataša
dc.creatorJurkowski, Tomasz
dc.creatorVidaković, Melita
dc.date.accessioned2022-02-10T10:26:44Z
dc.date.available2022-02-10T10:26:44Z
dc.date.issued2020
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/4783
dc.description.abstractSince our previous work indicated interplay of Ten-eleven translocation (TET) and Poly (ADP-ribose) polymerase (PARP) proteins our aim was to further study the effects of their interaction. The ability of recombinant PARP-1 to poly ADP-ribosylate (PARylate) catalytic domains of TET proteins was examined in vitro. It was observed that all TETs (TET1, TET2, TET3) readily undergo PARylation. To our knowledge, this is the first report of PARP-1 PARylation of TET2 and TET3 while TET1 PARylation has been previously documented. PARylation of TET proteins was evidenced by western blot signal stretching from the position of unmodified TET. This type of signal is characteristic for PARylation since proteins are modified to varying degrees by covalently attached negatively charged PAR polymers. This slows their movement during electrophoresis and individual molecules are expected to stop at different positions resulting in signal stretching upwards. PARylation can introduce electrostatic and topological changes in modified proteins, resulting in altered enzymatic activity. Therefore we evaluated TET1 activity in vitro using an ELISA type in-house assay, which showed that PARP-1-dependent PARylation lowers the ability of TET1 catalytic domain to oxidize 5mC to 5hmC. To corroborate these results in cellulo, we examined changes in DNA methylation in mouse embryonic fibroblasts (NIH3T3) compared to a PARP-1 knock out mouse embryonic fibroblast cell line (P ARP-/-). Lower methylation was observed in PARP-/- cells by immunocytochemical staining. Next, we analyzed global DNA methylation by ELISA assay and we again detected lower methylation levels in PARP-/- and also in NIH3T3 cells treated by a PARP inhibitor niraparib. Finally, DNA hydroxymethylation was assessed by immunocytochemistry and stronger signal was observed in PARP-/- cells and NIH3T3 cells treated by niraparib, compared to control NIH3T3 cells. In summary, inhibition of PARylation or absence of PARP-1 lead to decreased methylation and increased hydroxymethylation of DNA in cellulo. Together, our results point to the inhibitory influence that PARP-1 and PARylation exert on TET1 activity. Further studies are needed to evaluate the effects of PARylation of other TET proteins as well as to examine potential influence of other PARPs.sr
dc.language.isoensr
dc.publisherCold Spring Harbor Laboratorysr
dc.rightsopenAccesssr
dc.source2020 virtual meeting on EPIGENETICS & CHROMATIN; 2020 Sep 15-18; Virtual meetingsr
dc.titlePARP-1 and PARylation inhibit TET1 demethylation activitysr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.rights.holder© 2020 by the Cold Spring Harbor Laboratorysr
dc.description.otherAbstracts of papers presented at the 2020 virtual meeting on Epigenetics and Chromatin; 2020 Sep 15-18; Virtual meeting. Cold Spring Harbor: Laboratory; 2020. p. 286.sr
dc.citation.spage286
dc.type.versionpublishedVersionsr
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/9975/bitstream_9975.pdf
dc.citation.rankM34
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_ibiss_4783


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record